Epista Life Science A/S: Financial statements 2015
CVR: 32141064
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Epista Life Science A/S (CVR 32141064) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 20,392,956 and a net result of DKK 1,325,618 compared with DKK 2,378,521 the year before. That is an increase of 26.2% compared with the year before. Equity in the 2015 report amounted to DKK 3,604,751. The solvency ratio was 47.6%.
- Gross Profit
- DKK 20,392,956
- Profit/Loss
- DKK 1,325,618
- Equity
- DKK 3,604,751
- Total Assets
- DKK 7,573,847
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 20.4M | 1.3M | 3.6M | - |
| 2014 | - | 16.2M | 2.4M | 1.8M | - |
| 2013 | - | 10.9M | 1.5M | 1.2M | - |
| 2012 | - | 7.8M | 471K | 678K | - |
Official annual report
How creditworthy is Epista Life Science A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 1, 2015, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Epista Life Science A/S.
As of September 1, 2015, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Epista Life Science A/S.
Epista Life Science A/S has published its annual report for 2014. Gross profit came to DKK 16,152,951, and the net result was DKK 2,378,521.
About Epista Life Science A/S
Epista Life Science A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2009. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named EPISTA IT A/S and EPISTA IT ApS. The management consists of Per Erik Mikael Johansson. The board consists of Simon Carl Vilhelm Larsson (chair), Katarína Larsen and Klavs Esbjerg. The company is owned by Enhance BidCo ApS. The company has 86 employees (2026). In 2025, the company reported a gross profit of DKK 104,009,512 and a net result of DKK -40,340,814 compared with DKK -12,458,230 the year before. Equity in the 2025 report amounted to DKK 42,811,282.
